Breakthrough: Clinical trial shows that anti-inflammatory drug greatly reduces risk of cardiac events and the onset of cancer
A recent clinical trial for an anti-inflammatory drug has yielded encouraging results for patients who have previously suffered a heart attack. The drug in question, canakinumab, was tested on 10,000 patients who had already experienced …